Table 4.
Univariate Analysis | |||
---|---|---|---|
Outcome | |||
DSS | OS | Progression | |
Clinicopathological Parameters | |||
pT | p=0.080 | p=0.083 | p=0.061 |
TNM stage grouping | p=0.007 | p=0.024 | p=0.039 |
Organ confined disease status | p=0.016 | p=0.021 | p=0.010 |
Lymph node status | p=0.050 | p=NS | p=0.010 |
Lymphovascular invasion | p=0.020 | p=0.002 | p=0.060 |
Divergent aggressive histology | p=0.005 | p=0.029 | p=0.031 |
Concomitant CIS | p=NS | p=0.008 | p=NS |
mTOR Markers | |||
Pten | p=NS | p=NS | p=NS |
Phos Akt | p=NS | p=NS | p=NS |
Phos S6 | p=0.001 | p=0.01 | p=0.05 |
4 EBP-1 | p=NS | p=NS | p=NS |
c-Myc | p=NS | p=NS | p=0.01 |
P27 | p=NS | p=NS | p=NS |